Balance Sheet Data

Gilead Sciences, Inc. (GILD)

$72.7

-0.32 (-0.44%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 25,8407,9107,8297,6308,42813,370.3214,034.8714,732.4515,464.7016,233.34
Total Cash (%)
Account Receivables 3,5824,8924,4934,7774,6604,948.215,194.155,452.325,723.326,007.79
Account Receivables (%)
Inventories 2,0673,0142,7342,8203,3663,084.243,237.543,398.453,567.373,744.68
Inventories (%)
Accounts Payable 713844705905550826.71867.80910.94956.211,003.74
Accounts Payable (%)
Capital Expenditure -825-650-579-728-585-754.53-792.03-831.39-872.72-916.09
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.